Blog Layout

Market Commentary | March 2021

Rob Kellogg, CFA®

Apr 08, 2021

As discussed in last month’s commentary, we felt November was going to be one of the more pivotal months that this country has seen in quite some time. Well, November lived up to its billing. As the page turned to the final month of the year, November experienced one of the most divisive U.S. Presidential Elections, the announcement of multiple vaccines’ effectiveness, and new all-time highs in the equity markets. December is sure to be intense as well while President Trump continues to contest the election, and as many states are determining how to handle the rise in cases of COVID-19 in tandem with the potential distribution of a vaccine. December will close the book on what has been one of the most interesting years in many of our lifetimes. We will keep this month’s commentary brief as we look forward to recapping the year in our annual commentary next month.

THE MARKET

Equity markets experienced a historic month in November as the S&P 500 finished up 10.75% and is now up 12.10% on the year. 

The Dow Jones Industrial Average (DJIA) is now up 3.86% on the year after finishing the month of November up 11.84%. The technology heavy NASDAQ continues to perform well in 2020 as it is now up 35.96% on the year after finishing the month up 11.80%. Small cap stocks led the monthly performance numbers as the Russell 2000 is now up on the year by 9.07% after a tremendous month of November saw it increase by 18.29%.1 That is the strongest ever monthly performance for the index.2 Monday, November 30th, saw a dip in the markets to close out the month as monthly rebalancing likely trimmed the equity exposure in portfolios and investors were eager to lock in the gains experienced in November.

IMPACT OF THE ELECTION AND THE VIRUS

A large part of the monthly gains can likely be attributed to two factors. The U.S. Presidential Election has led to political certainty and there was positive news surrounding a COVID-19 vaccine. Investors are in favor of the political certainty as President Elect Joe Biden was able to defeat President Donald Trump in the November 3rd election. President Trump continues to contest the election, but he has yet to have any significant wins in court. President Elect Biden named Janet Yellen as his pick for U.S. Treasury Secretary. It is not expected to face much resistance in the Senate; however, she will need 51 votes to be confirmed. If Republicans maintain their majority of 52 seats after the Georgia runoff, Democrats will need to swing 3 senators to confirm her. If she is confirmed, she will be the first female to hold the role. She will be a welcome sight for Progressives as she served as the Chair of the Federal Reserve during the former President Obama’s second term. She was later replaced by Jerome Powell as Chair after Trump’s 2016 campaign targeted her for keeping interest rates too low. Current Secretary Mnuchin said that he will work with his successor “if things get certified,” which should further put investors’ minds at ease.3


As the election results became clearer, so too, did news regarding vaccine trials. Pfizer, BioNTech, Moderna, and AstraZeneca all announced positive news regarding late stage trials of a vaccine.4 From the perspective of many investors, this positive news was able to outweigh the increased number of virus cases, thus causing markets to rally throughout the month. The image to the right shows the daily number of virus cases throughout the year.


The United Kingdom gave emergency authorization on Wednesday, December 2nd, to Pfizer’s coronavirus vaccine. This makes them the first Western country to approve a vaccine for distribution. With the vaccine being codeveloped by an American company, this authorization puts more pressure on U.S. regulators to move faster.6 Federal government officials are promising that a vaccine will come soon, and some have even said before Christmas.7 However, only a limited number of vaccines will be available for immediate distribution following any sort of approval. As a result, a plan must be put in place to best curb the spread of the virus and to protect those most at risk. In a recent meeting, the Centers for Disease Control and Prevention (CDC) voted on which groups of people will be the first to receive the vaccine. In a 13-to-1 vote, it was decided that health care workers and residents of nursing homes and other residential care facilities will be first in line.8 The rest of the country may have to wait until late spring or potentially even until the summer of 2021.7 While we still may be months away from a widely distributable vaccine, the recent news on effectiveness of the vaccines and the news from Britain shows us that there is a light at the end of the tunnel.

CONCLUSION

With all of the news surrounding the election, the virus, and the markets, it can be difficult, and certainly stressful contemplating your investments. The good news is that you shouldn’t have to make sense of it all. Your financial plans should be built based on your own risk tolerance and your own financial objectives. The ebbs and flows of the markets will come and go with each new headline and each passing day, but your portfolios should be built to withstand the volatility. We will inevitably experience more negative news surrounding the virus. There are likely to be more lockdowns in certain parts of the country and visiting family over Christmas could become more controversial than it was over the Thanksgiving break. There will be positive news too. Recent unemployment applications fell last week after a recent jump signaling that layoffs are easing, even though they remain high as the labor market continues to recover.10 More positive developments on the vaccine front are likely as well. The resulting short term market fluctuations may be tough to look at as they scroll across the bottom of your television, but it is important to remember that your money exposed to this risk is meant for longer term goals. Remember to maintain your disciplined investment approach and take the emotion out of investing. Understanding your portfolio is about understanding expectations. It’s about having a sense of how your portfolio is designed and how it should behave over meaningful periods of time. Having a sense of how the investments should react to certain movements in the market. Having a dynamic plan in place should put your mind at ease when volatility is high. Please don’t hesitate to reach out if you’d like to revisit your risk tolerance and asset allocation. It is important that you feel comfortable about your current portfolio as December is likely to continue with the volatility seen thus far in 2020.

1 https://www.investing.com/indices/

2 https://www.reuters.com/article/us-usa-stocks/sp-500-ends-down-after-rallying-to-best-november-ever-idUSKBN28A1MH

3 https://www.foxbusiness.com/markets/if-treasury-secretary-janet-yellen-make-history

4 https://www.cnbc.com/2020/12/01/world-stocks-outperform-the-us-in-bumper-november.html

5 https://covid.cdc.gov/covid-data-tracker/#trends_totalandratecases

6 https://www.nytimes.com/2020/12/02/world/europe/pfizer-coronavirus-vaccine-approved-uk.html

7 https://www.cnn.com/2020/11/30/health/covid-vaccine-questions-when/index.html

8 https://www.webmd.com/lung/news/20201201/cdc-votes-on-who-should-get-covid-vaccine-first

9 https://www.juliusbaer.com/es/insights/artificial-intelligence/the-robots-keep-coming-finance-gets-techier/

10 https://www.wsj.com/articles/weekly-jobless-claims-coronavirus-13-2-2020-11606950268

 21

Returns are based on the S&P 500 Total Return Index, an unmanaged, capitalization-weighted index that measures the performance of 500 large capitalization domestic stocks representing all major industries. Indices do not include fees or operating expenses and are not available for actual investment. The hypothetical performance calculations are shown for illustrative purposes only and are not meant to be representative of actual results while investing over the time periods shown. The hypothetical performance calculations for the respective strategies are shown gross of fees. If fees were included returns would be lower. Hypothetical performance returns reflect the reinvestment of all dividends. The hypothetical performance results have certain inherent limitations. Unlike an actual performance record, they do not reflect actual trading, liquidity constraints, fees and other costs. Also, since the trades have not actually been executed, the results may have under- or overcompensated for the impact of certain market factors such as lack of liquidity. Simulated trading programs in general are also subject to the fact that they are designed with the benefit of hindsight. Returns will fluctuate and an investment upon redemption may be worth more or less than its original value. Past performance is not indicative of future returns. An individual cannot invest directly in an index.


This material has been prepared for information and educational purposes and should not be construed as a solicitation for the purchase or sell of any investment. The content is developed from sources believed to be reliable. This information is not intended to be investment, legal or tax advice. Investing involves risk, including the loss of principal. No investment strategy can guarantee a profit or protect against loss in a period of declining values. Investment advisory services offered by duly registered individuals on behalf of ChangePath, LLC a Registered Investment Adviser.

Index Returns (as of 11/30/2020) Level November QTD YTD
S&P 500 3621 10.75% 7.69% 12.10%
Dow Jones Industrial Average 29639 11.84% 6.68% 3.86%
NASDAQ Composite 12199 11.80% 9.23% 35.96%
Russell 2000 1820 18.29% 20.70% 9.07%
MSCI EAFE 2054 15.38% 10.70% 0.83%
MSCI Emerging Markets 1205 9.21% 11.37% 8.11%
U.S. Aggregate Bond - 0.98% 0.62% 7.36%

Source (1)

Source (5)

Source (9)

THE MARKET

After a volatile month, the S&P 500 finished at a record high when the markets closed on March 31st. The index finished the month up 4.24% and is now up 5.77% on the year. As the economic recovery continues, the Dow Jones Industrial Average led the monthly performance numbers as it finished up 6.62% and is now up 7.76% on the year. The technology heavy NASDAQ finished the month in positive territory, but it continues to lag the other two indices after outperforming both in 2020. The index finished the month up 0.41% and is now up 2.78% on the year. Small cap stocks continued to inch higher as the Russell 2000 ended the month up 0.88% and is now up 12.44% on the year. The MSCI EAFE index is up just under 3% on the year after a positive month, however the MSCI Emerging Markets index fell 1.70% during the month and is now up 1.95% on the year. The Bloomberg Barclay’s U.S. Aggregate Bond index fell 1.25% in March and is now down 3.37% on the year.1

Index Returns (as of 3/31/2021) Level March QTD/YTD
S&P 500 3972.89 4.24% 5.77%
Dow Jones Industrial Average 32981.55 6.62% 7.76%
NASDAQ Composite 13246.87 0.41% 2.78%
Russell 2000 2220.52 0.88% 12.44%
MSCI EAFE 2208.32 1.82% 2.83%
MSCI Emerging Markets 1316.43 -1.70% 1.95%
U.S. Aggregate Bond - -1.25 -3.37%

Source (1)

THE ECONOMY

As has been the case for much of the last year, the economy is shaped in large part by the pandemic and our country’s policy response to challenges that have come to light because of the virus. The first quarter of 2021 was one of transition. There was the transition in the White House and on Capitol Hill, and towards implementation of the Covid-19 vaccine. The transition in Washington, D.C. will dictate our country’s policy response to the virus while the vaccines have taken center stage regarding the pandemic.


Since March of 2020, the economy has experienced a massive drop followed by a surge and we continue to inch forward in our new social distancing driven economy. Final numbers for GDP growth in the fourth quarter of 2020 came in at 4.3%.2 The month of March closed with strong economic numbers and estimates for first quarter GDP growth are now at 6%. GDP numbers are seasonally adjusted annual rates. In March, personal consumption growth increased from 5.6% to 6.9% and private investment growth increased from 2.4% to 6.9%.3 The ISM Index also reaching its highest level since 1983 as it climbed to 64.7 in March, up from 60.8 in February.4 Goldman Sachs now estimates GDP to finish the year up 8% year over year which would signal a full recovery to pre-pandemic levels. For reference, U.S. GDP has not grown 8% in a year since 1951.5


Nonfarm payrolls increased by almost 1,000,000 in March and the unemployment rate fell to 6.0%, an improvement from 6.2% in February.6 Unemployment reached its pandemic peak of 14.8% in April of 2020. After the announcement of the most recent stimulus package in March, the Fed estimated inflation will reach 2.4% this year, above its previous estimate of 1.8%.7 Earnings for companies in the S&P 500 were down 11% in 2020, however, they are projected to increase by over 25% in 2021.8 That is positive news for equities, but we do want to exercise caution as we look at estimates in 2022. Higher interest rates could cause wage growth, there is the potential for higher corporate taxes, and the economy could slow as we enter 2022. Regarding the Fed, following their recent meeting on St. Patrick’s Day in March, they plan to maintain the target federal funds rate of 0-0.25 bps through 2023 and continue bond purchases throughout the remainder of 2021.9 If the economy does perform as well as expected to close out 2021, it’s possible that the Fed may need to taper back bond purchases in 2022 to curb fears of inflation. As of now, inflation is still in a relatively comfortable range, but it is worth monitoring as more financial stimulus enters the economy.

THE VIRUS

As the first quarter came to an end in 2020, we were still in the early stages of the pandemic, local governments were just starting their lockdowns, and every news station had a permanent number on the side of their screen tracking the growth of coronavirus cases. Twelve months later we are still tracking cases and fatalities, but just as important is tracking our progress towards herd immunity. Herd immunity can potentially be achieved through a combination of tracking those that have been infected by the virus along with those that have been vaccinated. The first image below shows the large decrease in cases and deaths on a 7-day moving average in the first quarter of 2021 due in large part to the roll out of the vaccines. As you can see in the second image, the total number infected by the virus is starting to plateau and the number of those vaccinated is beginning to increase.

Source (10)

Source (10) - *Share of the total population that has received at least one vaccine dose. **Est. Infected represents the number of people who may have been infected by COVID-19 by using the CDC’s estimate that 1 in 4.6 COVID-19 infections were reported. ***Est. Infected & vaccinated only assumes those infected equally likely to be vaccinated as those not infected. 

The percentage of the population experiencing immunity has increased to over fifty percent at the end of the first quarter, and J.P. Morgan’s analysts project that we will enter the 60-80% zone of herd immunity in April (65%) and surpass the zone by the end of the second quarter (85%).11 These numbers are supported by the image below showing the results of a recent Gallup poll. The percentage of Americans willing to get the vaccine has increased from 50% in September of 2020 up to 74% in March of 2021.12 The important note is that we are making progress towards herd immunity. These numbers lead us to believe that we will be in a much better spot regarding the pandemic as we enter the third quarter of 2021.

Source (12)

POLICY RESPONSE

President Joe Biden signed the $1.9 trillion American Rescue Plan on March 11th. It provided direct $1,400 payments to Americans making under $75,000. It also provided aid to state and local governments, extended unemployment benefits, expanded tax credits, provided aid to small business, and helped with the Covid-19 response.13

Source (13)

The plan was an economic aid package designed to help Americans and businesses survive the pandemic downturn. However, the plan did little to advance Biden’s long term economic agenda when it comes to infrastructure and transitioning to renewable energy, so on Wednesday, March 31st, President Biden introduced the American Jobs Plan. The bulk of the plan is to be spent on infrastructure with over $600 billion dedicated to transportation infrastructure (highways, public transit) and another $600 billion going to community infrastructure (clean drinking water, housing, schools, VA hospitals). $580 billion will go towards research and development, manufacturing, and workforce development. The plan is rounded out with $400 million dedicated to improving elderly care.14 The plan will still need to go through Congress, but it is likely that at least some trimmed down version of the plan is passed. How is the plan going to be funded? The likely solution is Biden’s Made in America Tax Plan that would undo a lot of changes from former President Trump’s Tax Cuts and Jobs Act in 2017. The main change is raising the corporate tax rate from 21% to 28% which is expected to raise the $2 trillion needed for funding over the next 15 years. The American Jobs Plan is the first of two plans that Biden will introduce following the passing of the American Rescue Plan. The next plan, likely to be introduced in April, will be the American Family Plan that will aim to address healthcare and education.15 This plan will also try to extend benefits to lower and middle-income earners targeting three programs: expanding the Earned Income Tax Credit to help more Americans over the age of 65, the Dependent Care Credit for help with daycare allowing both spouses to return to work, and the Child Tax Credit.11

CONCLUSION

It has now been a full calendar year since markets experienced their massive correction due to the pandemic, and the S&P 500 ended the month of March at a new record high. It was a bumpy ride as there were concerns regarding the potential for higher inflation and rising bond yields, specifically the 10-year treasury. As alluded to earlier, corporate earnings are set to see growth of over 25% in 2021, the economy is likely to continue its expansion as U.S. real GDP is estimated at 8% growth in 2021, and more Americans are financially stable with money to spend due to a combination of financial stimulus along with pent up demand. All of those bode well for equities. However, potential inflation could prove negative for equities, and it will likely mean increased volatility throughout the remainder of the year. Even though rising yields are not a good sign for bonds, it is wise to maintain fixed income exposure due to its low correlation to equities. We recommend staying in your asset allocation driven risk-based portfolios due to the uncertainties regarding the economic recovery. We have never experienced a recovery from a pandemic in modern times, so we can’t confidently predict exactly how things will unfold. We do know that value stocks usually perform better in higher inflationary environments, but also that we do need exposure to growth as the year comes to an end and the economic recovery begins to slow. International equities still look relatively cheap from a valuation perspective and should yield higher dividends compared to their counterparts in the United States. International fixed income and emerging market debt are also providing stronger yields with higher credit quality than past years. The important take away is that there are meaningful reasons to maintain a diversified approach based on your risk tolerance, and why each asset class should have some exposure in your portfolios. It is imperative that you have the right expectations for how your portfolio should perform. If you’d like to review those expectations or revisit your risk tolerance, please don’t hesitate to reach out

1 https://www.investing.com/indices/major-indices

2 https://www.bea.gov/news/2021/gross-domestic-product-third-estimate-gdp-industry-and-corporate-profits-4th-quarter-and

3 https://www.frbatlanta.org/cqer/research/gdpnow

4 https://www.cnbc.com/2021/04/01/ism-manufacturing-march-2021.html

5 https://www.axios.com/goldman-sachs-us-economy-grow-8-per-cent-2021-eb7e1d84-b6fa-483a-9e19-37a7faddadc0.html

6 https://www.cnbc.com/2021/04/02/us-jobs-report-march-2021.html

7 https://www.cnbc.com/2021/03/17/heres-where-the-federal-reserve-sees-interest-rates-the-economy-and-inflation-going-in-the-future.html

8 https://www.factset.com/hubfs/Website/Resources%20Section/Research%20Desk/Earnings%20Insight/EarningsInsight_032621A.pdf

9 https://www.federalreserve.gov/monetarypolicy/files/monetary20210317a1.pdf

10 Centers for Disease Control and Prevention, Johns Hopkins CSSE, Our World in Data, J.P. Morgan Asset Management. Guide to the Markets – U.S. Data are as of March 31, 2021.

11 https://am.jpmorgan.com/us/en/asset-management/protected/adv/insights/market-insights/guide-to-the-markets/

12 https://news.gallup.com/poll/342431/satisfaction-vaccine-rollout-surges.aspx

13 https://www.statista.com/chart/24395/composition-of-the-american-rescue-plan-act/

14 https://www.investopedia.com/what-s-in-joe-biden-s-usd2-trillion-american-jobs-plan-5120273

15 https://www.forbes.com/advisor/personal-finance/biden-american-jobs-plan/

Returns are based on the S&P 500 Total Return Index, an unmanaged, capitalization-weighted index that measures the performance of 500 large capitalization domestic stocks representing all major industries. Indices do not include fees or operating expenses and are not available for actual investment. The hypothetical performance calculations are shown for illustrative purposes only and are not meant to be representative of actual results while investing over the time periods shown. The hypothetical performance calculations for the respective strategies are shown gross of fees. If fees were included returns would be lower. Hypothetical performance returns reflect the reinvestment of all dividends. The hypothetical performance results have certain inherent limitations. Unlike an actual performance record, they do not reflect actual trading, liquidity constraints, fees and other costs. Also, since the trades have not actually been executed, the results may have under- or overcompensated for the impact of certain market factors such as lack of liquidity. Simulated trading programs in general are also subject to the fact that they are designed with the benefit of hindsight. Returns will fluctuate and an investment upon redemption may be worth more or less than its original value. Past performance is not indicative of future returns. An individual cannot invest directly in an index.


This material has been prepared for information and educational purposes and should not be construed as a solicitation for the purchase or sell of any investment. The content is developed from sources believed to be reliable. This information is not intended to be investment, legal or tax advice. Investing involves risk, including the loss of principal. No investment strategy can guarantee a profit or protect against loss in a period of declining values. Investment advisory services offered by duly registered individuals on behalf of ChangePath, LLC a Registered Investment Adviser.

03 Dec, 2021
November was a dizzying month for investors. The highlight? Earnings. 82% of companies1 beat estimates this quarter, despite headwinds such as supply chain constraints and inflation. The market’s biggest muse? Elon Musk’s twitter handle, with tweets such as (paraphrased) “should I sell 10% of my Tesla stock?” The most exciting job? Fed watcher. We started tapering, saw a plethora of hot inflation data, and gleaned insight from Federal Reserve Chair Jerome Powell on the last day of the month. November 2021 Market Returns 
03 Dec, 2021
October was another positive month for the markets after September’s pullback. So far in 2021, the S&P 500 had nine positive performing months, September being the only hold out. The index ended up 6.9%, even though the first week of the month started a bit volatile. However, 2021 is looking robust, even if November and December aren’t large contributors, as the YTD performance through October is 23.9%. 1 
By Rob Kellogg, CFA® 07 Oct, 2021
As discussed in last month’s commentary, we felt November was going to be one of the more pivotal months that this country has seen in quite some time. Well, November lived up to its billing. As the page turned to the final month of the year, November experienced one of the most divisive U.S. Presidential Elections, the announcement of multiple vaccines’ effectiveness, and new all-time highs in the equity markets. December is sure to be intense as well while President Trump continues to contest the election, and as many states are determining how to handle the rise in cases of COVID-19 in tandem with the potential distribution of a vaccine. December will close the book on what has been one of the most interesting years in many of our lifetimes. We will keep this month’s commentary brief as we look forward to recapping the year in our annual commentary next month.
By Rob Kellogg, CFA® 07 Sep, 2021
As discussed in last month’s commentary, we felt November was going to be one of the more pivotal months that this country has seen in quite some time. Well, November lived up to its billing. As the page turned to the final month of the year, November experienced one of the most divisive U.S. Presidential Elections, the announcement of multiple vaccines’ effectiveness, and new all-time highs in the equity markets. December is sure to be intense as well while President Trump continues to contest the election, and as many states are determining how to handle the rise in cases of COVID-19 in tandem with the potential distribution of a vaccine. December will close the book on what has been one of the most interesting years in many of our lifetimes. We will keep this month’s commentary brief as we look forward to recapping the year in our annual commentary next month.
By Rob Kellogg, CFA® 05 Aug, 2021
As discussed in last month’s commentary, we felt November was going to be one of the more pivotal months that this country has seen in quite some time. Well, November lived up to its billing. As the page turned to the final month of the year, November experienced one of the most divisive U.S. Presidential Elections, the announcement of multiple vaccines’ effectiveness, and new all-time highs in the equity markets. December is sure to be intense as well while President Trump continues to contest the election, and as many states are determining how to handle the rise in cases of COVID-19 in tandem with the potential distribution of a vaccine. December will close the book on what has been one of the most interesting years in many of our lifetimes. We will keep this month’s commentary brief as we look forward to recapping the year in our annual commentary next month.
By Rob Kellogg, CFA® 05 Jun, 2021
As discussed in last month’s commentary, we felt November was going to be one of the more pivotal months that this country has seen in quite some time. Well, November lived up to its billing. As the page turned to the final month of the year, November experienced one of the most divisive U.S. Presidential Elections, the announcement of multiple vaccines’ effectiveness, and new all-time highs in the equity markets. December is sure to be intense as well while President Trump continues to contest the election, and as many states are determining how to handle the rise in cases of COVID-19 in tandem with the potential distribution of a vaccine. December will close the book on what has been one of the most interesting years in many of our lifetimes. We will keep this month’s commentary brief as we look forward to recapping the year in our annual commentary next month.
By Rob Kellogg, CFA® 07 May, 2021
As discussed in last month’s commentary, we felt November was going to be one of the more pivotal months that this country has seen in quite some time. Well, November lived up to its billing. As the page turned to the final month of the year, November experienced one of the most divisive U.S. Presidential Elections, the announcement of multiple vaccines’ effectiveness, and new all-time highs in the equity markets. December is sure to be intense as well while President Trump continues to contest the election, and as many states are determining how to handle the rise in cases of COVID-19 in tandem with the potential distribution of a vaccine. December will close the book on what has been one of the most interesting years in many of our lifetimes. We will keep this month’s commentary brief as we look forward to recapping the year in our annual commentary next month.
By Rob Kellogg, CFA® 05 May, 2021
As discussed in last month’s commentary, we felt November was going to be one of the more pivotal months that this country has seen in quite some time. Well, November lived up to its billing. As the page turned to the final month of the year, November experienced one of the most divisive U.S. Presidential Elections, the announcement of multiple vaccines’ effectiveness, and new all-time highs in the equity markets. December is sure to be intense as well while President Trump continues to contest the election, and as many states are determining how to handle the rise in cases of COVID-19 in tandem with the potential distribution of a vaccine. December will close the book on what has been one of the most interesting years in many of our lifetimes. We will keep this month’s commentary brief as we look forward to recapping the year in our annual commentary next month.
By Rob Kellogg, CFA® 09 Mar, 2021
As discussed in last month’s commentary, we felt November was going to be one of the more pivotal months that this country has seen in quite some time. Well, November lived up to its billing. As the page turned to the final month of the year, November experienced one of the most divisive U.S. Presidential Elections, the announcement of multiple vaccines’ effectiveness, and new all-time highs in the equity markets. December is sure to be intense as well while President Trump continues to contest the election, and as many states are determining how to handle the rise in cases of COVID-19 in tandem with the potential distribution of a vaccine. December will close the book on what has been one of the most interesting years in many of our lifetimes. We will keep this month’s commentary brief as we look forward to recapping the year in our annual commentary next month.
By Rob Kellogg, CFA® 05 Feb, 2021
As discussed in last month’s commentary, we felt November was going to be one of the more pivotal months that this country has seen in quite some time. Well, November lived up to its billing. As the page turned to the final month of the year, November experienced one of the most divisive U.S. Presidential Elections, the announcement of multiple vaccines’ effectiveness, and new all-time highs in the equity markets. December is sure to be intense as well while President Trump continues to contest the election, and as many states are determining how to handle the rise in cases of COVID-19 in tandem with the potential distribution of a vaccine. December will close the book on what has been one of the most interesting years in many of our lifetimes. We will keep this month’s commentary brief as we look forward to recapping the year in our annual commentary next month.
More Posts
Share by: